Facial Plast Surg 2020; 36(06): 688-695
DOI: 10.1055/s-0040-1721115
Original Article

Tissue Modification in Nonsurgical Facelift Options

Lucas M. Harrison
1   Department of Plastic Surgery, Wright State University, Dayton, Ohio
,
Ryan Shapiro
1   Department of Plastic Surgery, Wright State University, Dayton, Ohio
,
R Michael Johnson
1   Department of Plastic Surgery, Wright State University, Dayton, Ohio
› Author Affiliations

Abstract

Nonsurgical facelifts are a term for a heterogeneous group of procedures used by physicians to improve facial rejuvenation without the use of operative techniques. Patients demand these services due to the reduced recovery time and generally lower risk. However, nonsurgical techniques, to be effective, must induce conformational change in the cells and tissues of the face. Therefore, these techniques are significant procedures that have associated risks. Understanding the tissue modifications and mechanisms of action of these techniques is vital to their safe and effective use. The purpose of this article is to provide a background of tissue modification in nonsurgical facelift options.



Publication History

Article published online:
24 December 2020

© 2020. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Jacono AA, Malone MH, Lavin TJ. Nonsurgical facial rejuvenation procedures in patients under 50 prior to undergoing facelift: habits, costs, and results. Aesthet Surg J 2017; 37 (04) 448-453
  • 2 Huang W, Foster JA, Rogachefsky AS. Pharmacology of botulinum toxin. J Am Acad Dermatol 2000; 43 (02) , Pt 1 249-259
  • 3 Sadick NS, Herman AR. Comparison of botulinum toxins A and B in the aesthetic treatment of facial rhytides. Dermatol Surg 2003; 29 (04) 340-347
  • 4 Sharma S, Zhou Y, Singh BR. Cloning, expression, and purification of C-terminal quarter of the heavy chain of botulinum neurotoxin type A. Protein Expr Purif 2006; 45 (02) 288-295
  • 5 Sundaram H, Signorini M, Liew S. et al. Global Aesthetics Consensus Group. Global aesthetics consensus: botulinum toxin type A--evidence-based review, emerging concepts, and consensus recommendations for aesthetic use, including updates on complications. Plast Reconstr Surg 2016; 137 (03) 518e-529e
  • 6 Carruthers J, Carruthers A. The adjunctive usage of botulinum toxin. Dermatol Surg 1998; 24 (11) 1244-1247
  • 7 Vartanian AJ, Dayan SH. Facial rejuvenation using botulinum toxin A: review and updates. Facial Plast Surg 2004; 20 (01) 11-19
  • 8 Zimbler MS, Nassif PS. Adjunctive applications for botulinum toxin in facial aesthetic surgery. Facial Plast Surg Clin North Am 2003; 11 (04) 477-482
  • 9 Fagien S, Brandt FS. Primary and adjunctive use of botulinum toxin type A (Botox) in facial aesthetic surgery: beyond the glabella. Clin Plast Surg 2001; 28 (01) 127-148
  • 10 Cartee TV, Monheit GD. An overview of botulinum toxins: past, present, and future. Clin Plast Surg 2011; 38 (03) 409-426 , vi
  • 11 de Maio M. The minimal approach: an innovation in facial cosmetic procedures. Aesthetic Plast Surg 2004; 28 (05) 295-300
  • 12 Blitzer A, Binder WJ, Aviv JE, Keen MS, Brin MF. The management of hyperfunctional facial lines with botulinum toxin. A collaborative study of 210 injection sites in 162 patients. Arch Otolaryngol Head Neck Surg 1997; 123 (04) 389-392
  • 13 Brandt FS, Bellman B. Cosmetic use of botulinum A exotoxin for the aging neck. Dermatol Surg 1998; 24 (11) 1232-1234
  • 14 Carucci JA, Zweibel SM. Botulinum A exotoxin for rejuvenation of the upper third of the face. Facial Plast Surg 2001; 17 (01) 11-20
  • 15 Carruthers J, Carruthers A. BOTOX use in the mid and lower face and neck. Semin Cutan Med Surg 2001; 20 (02) 85-92
  • 16 Flynn TC, Carruthers JA, Carruthers JA. Botulinum-A toxin treatment of the lower eyelid improves infraorbital rhytides and widens the eye. Dermatol Surg 2001; 27 (08) 703-708
  • 17 Hankins CL, Strimling R, Rogers GS. Botulinum A toxin for glabellar wrinkles. Dose and response. Dermatol Surg 1998; 24 (11) 1181-1183
  • 18 Matarasso A, Matarasso SL, Brandt FS, Bellman B. Botulinum A exotoxin for the management of platysma bands. Plast Reconstr Surg 1999; 103 (02) 645-652 , discussion 653–655
  • 19 Dayan SH, Lieberman ED, Thakkar NN, Larimer KA, Anstead A. Botulinum toxin a can positively impact first impression. Dermatol Surg 2008; 34 (Suppl. 01) S40-S47
  • 20 Przylipiak M, Przylipiak J, Terlikowski R, Lubowicka E, Chrostek L, Przylipiak A. Improvements in the perception of facial attractiveness following surgical aesthetic treatment; study based on online before and after photos. J Cosmet Dermatol 2019; 18 (01) 296-300
  • 21 Keen M, Blitzer A, Aviv J. et al. Botulinum toxin A for hyperkinetic facial lines: results of a double-blind, placebo-controlled study. Plast Reconstr Surg 1994; 94 (01) 94-99
  • 22 Lowe NJ, Maxwell A, Harper H. Botulinum A exotoxin for glabellar folds: a double-blind, placebo-controlled study with an electromyographic injection technique. J Am Acad Dermatol 1996; 35 (04) 569-572
  • 23 Carruthers JA, Lowe NJ, Menter MA. et al. BOTOX Glabellar Lines I Study Group. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol 2002; 46 (06) 840-849
  • 24 Schlessinger J, Gilbert E, Cohen JL, Kaufman J. New uses of abobotulinumtoxinA in aesthetics. Aesthet Surg J 2017; 37 (Suppl. 01) S45-S58
  • 25 Zhibo X, Miaobo Z. Intralesional botulinum toxin type A injection as a new treatment measure for keloids. Plast Reconstr Surg 2009; 124 (05) 275e-277e
  • 26 Bi M, Sun P, Li D, Dong Z, Chen Z. Intralesional injection of botulinum toxin type a compared with intralesional injection of corticosteroid for the treatment of hypertrophic scar and keloid: a systematic review and meta-analysis. Med Sci Monit 2019; 25: 2950-2958
  • 27 Finn JC. Botulinum toxin type A: fine-tuning treatment of facial nerve injury. J Drugs Dermatol 2004; 3 (02) 133-137
  • 28 Diaspro A, Cavallini M, Piersini P, Sito G. Gummy smile treatment: proposal for a novel corrective technique and a review of the literature. Aesthet Surg J 2018; 38 (12) 1330-1338
  • 29 Quan T, Wang F, Shao Y. et al. Enhancing structural support of the dermal microenvironment activates fibroblasts, endothelial cells, and keratinocytes in aged human skin in vivo. J Invest Dermatol 2013; 133 (03) 658-667
  • 30 Tran C, Carraux P, Micheels P, Kaya G, Salomon D. In vivo bio-integration of three hyaluronic acid fillers in human skin: a histological study. Dermatology 2014; 228 (01) 47-54
  • 31 Bergeret-Galley C. Comparison of resorbable soft tissue fillers. Aesthet Surg J 2004; 24 (01) 33-46
  • 32 Rohrich RJ, Bartlett EL, Dayan E. Practical approach and safety of hyaluronic acid fillers. Plast Reconstr Surg Glob Open 2019; 7 (06) e2172
  • 33 Gutowski KA. Hyaluronic acid fillers: Science and clinical uses. Clin Plast Surg 2016; 43 (03) 489-496
  • 34 Percec I, Bertucci V, Solish N, Wagner T, Nogueira A, Mashburn J. An objective, quantitative, dynamic assessment of hyaluronic acid fillers that adapt to facial movement. Plast Reconstr Surg 2020; 145 (02) 295e-305e
  • 35 Jones DH. Semipermanent and permanent injectable fillers. Dermatol Clin 2009; 27 (04) 433-444 , vi
  • 36 Pavicic T. Calcium hydroxylapatite filler: an overview of safety and tolerability. J Drugs Dermatol 2013; 12 (09) 996-1002
  • 37 Bauer U, Graivier MH. Optimizing injectable poly-L-lactic acid administration for soft tissue augmentation: The rationale for three treatment sessions. Can J Plast Surg 2011; 19 (03) e22-e27
  • 38 Graivier MH, Bass LM, Lorenc ZP, Fitzgerald R, Goldberg DJ, Lemperle G. Differentiating nonpermanent injectable fillers: prevention and treatment of filler complications. Aesthet Surg J 2018; 38 (Suppl. 01) S29-S40
  • 39 Cohen JL, Biesman BS, Dayan SH. et al. Treatment of hyaluronic acid filler-induced impending necrosis with hyaluronidase: consensus recommendations. Aesthet Surg J 2015; 35 (07) 844-849
  • 40 Qureshi AA, Parikh RP, Sharma K, Myckatyn TM, Tenenbaum MM. Nonsurgical facial rejuvenation: outcomes and safety of neuromodulator and soft-tissue filler procedures performed in a resident cosmetic clinic. Aesthetic Plast Surg 2017; 41 (05) 1177-1183
  • 41 Freire Dos Santos MJ, Carvalho R, Arnaut LG. Split-face, randomized, placebo-controlled, double-blind study to investigate passive versus active dermal filler administration. Aesthetic Plast Surg 2018; 42 (06) 1655-1663
  • 42 Vallejo A, Garcia-Ruano AA, Pinilla C, Castellano M, Deleyto E, Perez-Cano R. Comparing efficacy and costs of four facial filelrs in human immunodeficiency virus – associated lipodystrophy: a clinical trial. Plast Reconstr Surg 2018; 141 (03) 613-623
  • 43 Moradi A, Shirazi A, Perez V. A guide to temporal fossa augmentation with small gel particle hyaluronic acid dermal filler. J Drugs Dermatol 2011; 10 (06) 673-676
  • 44 Jones D, Murphy DK. Volumizing hyaluronic acid filler for midface volume deficit: 2-year results from a pivotal single-blind randomized controlled study. Dermatol Surg 2013; 39 (11) 1602-1612
  • 45 Hall MB, Roy S, Buckingham ED. Novel use of a volumizing hyaluronic acid filler for treatment of infraorbital hollows. JAMA Facial Plast Surg 2018; 20 (05) 367-372
  • 46 Singh P, Vijayan R, Nikkhah D. Filler rhinoplasty: evidence, outcomes, and complications. Aesthet Surg J 2018; 38 (11) NP165-NP167
  • 47 Klein SM, Schreml S, Nerlich M, Prantl L. In vitro studies investigating the effect of subcutaneous phosphatidylcholine injections in the 3T3-L1 adipocyte model: lipolysis or lipid dissolution?. Plast Reconstr Surg 2009; 124 (02) 419-427
  • 48 Fagien S, McChesney P, Subramanian M, Jones DH. Prevention and management of injection-related adverse effects in facial aesthetics: considerations for ATX-101 (deoxycholic acid injection) treatment. Dermatol Surg 2016; 42 (Suppl. 01) S300-S304
  • 49 Sung CT, Lee A, Choi F, Juhasz M, Mesinkovska NA. Non-submental applications of injectable deoxycholic acid: A systematic review. J Drugs Dermatol 2019; 18 (07) 675-680
  • 50 Georgesen C, Lipner SR. The development, evidence, and current use of ATX-101 for the treatment of submental fat. J Cosmet Dermatol 2017; 16 (02) 174-179
  • 51 Humphrey S, Sykes J, Kantor J. et al. ATX-101 for reduction of submental fat: a phase III randomized controlled trial. J Am Acad Dermatol 2016; 75 (04) 788.e7-797.e7
  • 52 Jegasothy SM. Deoxycholic acid injections for bra-line lipolysis. Dermatol Surg 2018; 44 (05) 757-760
  • 53 Verma KD, Somenek MT. Deoxycholic acid injection as an effective treatment for reduction of posterior upper torso brassiere strap adiposity. Plast Reconstr Surg 2018; 141 (01) 200e-202e
  • 54 Sykes JM, Allak A, Klink B. Future applications of deoxycholic acid in body contouring. J Drugs Dermatol 2017; 16 (01) 43-46
  • 55 Shridharani SM. Novel surface anatomic landmarks of the jowl to guide treatment with ATX-101. Plast Reconstr Surg Glob Open 2019; 7 (10) e2459
  • 56 Shridharani SM. Improvement in jowl fat following ATX-101 treatment: results from a single-site study. Plast Reconstr Surg 2020; 145 (04) 929-935
  • 57 Sand JP, Nabili V, Kochhar A, Rawnsley J, Keller G. Platelet-rich plasma for the aesthetic surgeon. Facial Plast Surg 2017; 33 (04) 437-443
  • 58 Cervelli V, Gentile P, Scioli MG. et al. Application of platelet-rich plasma in plastic surgery: clinical and in vitro evaluation. Tissue Eng Part C Methods 2009; 15 (04) 625-634
  • 59 Frautschi RS, Hashem AM, Halasa B, Cakmakoglu C, Zins JE. Current evidence for clinical efficacy of platelet rich plasma in aesthetic surgery: a systematic review. Aesthet Surg J 2017; 37 (03) 353-362
  • 60 Eppley BL, Pietrzak WS, Blanton M. Platelet-rich plasma: a review of biology and applications in plastic surgery. Plast Reconstr Surg 2006; 118 (06) 147e-159e
  • 61 Elnehrawy NY, Ibrahim ZA, Eltoukhy AM, Nagy HM. Assessment of the efficacy and safety of single platelet-rich plasma injection on different types and grades of facial wrinkles. J Cosmet Dermatol 2017; 16 (01) 103-111
  • 62 Latalski M, Walczyk A, Fatyga M. et al. Allergic reaction to platelet-rich plasma (PRP): case report. Medicine (Baltimore) 2019; 98 (10) e14702
  • 63 Gawdat HI, Tawdy AM, Hegazy RA, Zakaria MM, Allam RS. Autologous platelet-rich plasma versus readymade growth factors in skin rejuvenation: a split face study. J Cosmet Dermatol 2017; 16 (02) 258-264
  • 64 Abuaf OK, Yildiz H, Baloglu H, Bilgili ME, Simsek HA, Dogan B. Histologic evidence of new collagen formulation using platelet rich plasma in skin rejuventation: a prospective controlled clinical study. Ann Dermatol 2016; 28 (06) 718-724
  • 65 Mehryan P, Zartab H, Rajabi A, Pazhoohi N, Firooz A. Assessment of efficacy of platelet-rich plasma (PRP) on infraorbital dark circles and crow's feet wrinkles. J Cosmet Dermatol 2014; 13 (01) 72-78
  • 66 Abu-Ghname A, Perdanasari AT, Davis MJ, Reece EM. Platelet-rich plasma: principles and applications in plastic surgery. Semin Plast Surg 2019; 33 (03) 155-161
  • 67 Liao HT, Marra KG, Rubin JP. Application of platelet-rich plasma and platelet-rich fibrin in fat grafting: basic science and literature review. Tissue Eng Part B Rev 2014; 20 (04) 267-276
  • 68 Alster TS, Graham PM. Microneedling: a review and practical guide. Dermatol Surg 2018; 44 (03) 397-404
  • 69 Ramaut L, Hoeksema H, Pirayesh A, Stillaert F, Monstrey S. Microneedling: where do we stand now? A systematic review of the literature. J Plast Reconstr Aesthet Surg 2018; 71 (01) 1-14
  • 70 Harris AG, Naidoo C, Murrell DF. Skin needling as a treatment for acne scarring: an up-to-date review of the literature. Int J Womens Dermatol 2015; 1 (02) 77-81
  • 71 Alster TS, Li MKY. Microneedling of scars: a large prospective study with long-term follow-up. Plast Reconstr Surg 2020; 145 (02) 358-364
  • 72 Min S, Park SY, Yoon JY, Suh DH. Comparison of fractional microneedling radiofrequency and bipolar radiofrequency on acne and acne scar and investigation of mechanism: comparative randomized controlled clinical trial. Arch Dermatol Res 2015; 307 (10) 897-904
  • 73 Hom DB, Harmon J. Dermabrasion for scars and wire loop electrocautery for rhinophyma. Facial Plast Surg 2019; 35 (03) 267-273
  • 74 Alkhawam L, Alam M. Dermabrasion and microdermabrasion. Facial Plast Surg 2009; 25 (05) 301-310
  • 75 Karimipour DJ, Karimipour G, Orringer JS. Microdermabrasion: an evidence-based review. Plast Reconstr Surg 2010; 125 (01) 372-377
  • 76 Karimipour DJ, Kang S, Johnson TM. et al. Microdermabrasion: a molecular analysis following a single treatment. J Am Acad Dermatol 2005; 52 (02) 215-223
  • 77 Coimbra M, Rohrich RJ, Chao J, Brown SA. A prospective controlled assessment of microdermabrasion for damaged skin and fine rhytides. Plast Reconstr Surg 2004; 113 (05) 1438-1443 , discussion 1444
  • 78 Shim EK, Barnette D, Hughes K, Greenway HT. Microdermabrasion: a clinical and histopathologic study. Dermatol Surg 2001; 27 (06) 524-530
  • 79 Boisnic S, Divaris M, Branchet M-C, Nelson AA. Split-face histological and biochemical evaluation of tightening efficacy using temperature- and impedance-controlled continuous non-invasive radiofrequency energy. J Cosmet Laser Ther 2017; 19 (03) 128-132
  • 80 Alexiades-Armenakas M, Rosenberg D, Renton B, Dover J, Arndt K. Blinded, randomized, quantitative grading comparison of minimally invasive, fractional radiofrequency and surgical face-lift to treat skin laxity. Arch Dermatol 2010; 146 (04) 396-405
  • 81 el-Domyati M, el-Ammawi TS, Medhat W. et al. Radiofrequency facial rejuvenation: evidence-based effect. J Am Acad Dermatol 2011; 64 (03) 524-535
  • 82 Sá GFF, Serpa C, Arnaut LG. Stratum corneum permeabilization with photoacoustic waves generated by piezophotonic materials. J Control Release 2013; 167 (03) 290-300
  • 83 Orringer JS, Sachs DL, Shao Y. et al. Direct quantitative comparison of molecular responses in photodamaged human skin to fractionated and fully ablative carbon dioxide laser resurfacing. Dermatol Surg 2012; 38 (10) 1668-1677
  • 84 Kislevitz M, Lu KB, Wamsley C, Hoopman J, Kenkel J, Akgul Y. Novel use of non-invasive devices and microbiopsies to assess facial skin rejuvenation following laser treatment. Lasers Surg Med 2020; 52 (09) 822-830
  • 85 Kinney BM, Kanakov D, Yonkova P. Histological examination of skin tissue in the porcine animal model after simultaneous and consecutive application of monopolar radiofrequency and targeted pressure energy. J Cosmet Dermatol 2020; 19 (01) 93-101
  • 86 Gold AH, Pozner J, Weiss R. A fractional bipolar radiofrequency device combined with a bipolar radiofrequency and infrared light treatment for improvement in facial wrinkles and overall skin tone and texture. Aesthet Surg J 2016; 36 (09) 1058-1067
  • 87 Samadi A, Nasrollahi SA, Janani L. et al. Combination of fractional radiofrequency and thermo-contraction systems for facial skin rejuvenation: a clinical and histological study. Aesthet Surg J 2018; 38 (12) 1341-1350
  • 88 Serdar ZA, Tatlıparmak A. Comparison of efficacy and safety of fractional radiofrequency and fractional Er:YAG laser in facial and neck wrinkles: six-year experience with 333 patients. Dermatol Ther (Heidelb) 2019; 32 (05) e13054
  • 89 Koren A, Isman G, Cohen S. et al. Efficacy of a combination of diluted calcium hydroxylapatite-based filler and an energy-based device for the treatment of facial atrophic acne scars. Clin Exp Dermatol 2019; 44 (05) e171-e176
  • 90 Mulholland RS. Radio frequency energy for non-invasive and minimally invasive skin tightening. Clin Plast Surg 2011; 38 (03) 437-448 , vi
  • 91 Kulick MI. Evaluation of the KTP 532 laser in aesthetic facial surgery. Aesthetic Plast Surg 1996; 20 (01) 53-57
  • 92 Fitzpatrick RE, Goldman MP, Dierickx C. Laser ablation of facial cosmetic tattoos. Aesthetic Plast Surg 1994; 18 (01) 91-98
  • 93 Rhie JW, Shim JS, Choi WS. A pilot study of skin resurfacing using the 2,790-nm erbium:YSGG laser system. Arch Plast Surg 2015; 42 (01) 52-58
  • 94 Wanner M, Tanzi EL, Alster TS. Fractional photothermolysis: treatment of facial and nonfacial cutaneous photodamage with a 1,550-nm erbium-doped fiber laser. Dermatol Surg 2007; 33 (01) 23-28
  • 95 Tierney EP, Hanke CW. Fractionated carbon dioxide laser treatment of photoaging: prospective study in 45 patients and review of the literature. Dermatol Surg 2011; 37 (09) 1279-1290
  • 96 Hantash BM, Bedi VP, Kapadia B. et al. In vivo histological evaluation of a novel ablative fractional resurfacing device. Lasers Surg Med 2007; 39 (02) 96-107
  • 97 Kim JE, Won CH, Bak H. et al. Gene profiling analysis of the early effects of ablative fractional carbon dioxide laser treatment on human skin. Dermatol Surg 2013; 39 (07) 1033-1043
  • 98 Jiang X, Ge H, Zhou C, Chai X, Deng H. The role of transforming growth factor β1 in fractional laser resurfacing with a carbon dioxide laser. Lasers Med Sci 2014; 29 (02) 681-687
  • 99 Saluja R, Gentile RD. Picosecond laser: tattoos and skin rejuvenation. Facial Plast Surg Clin North Am 2020; 28 (01) 87-100
  • 100 Suh J-J, Lee J, Park J-C, Lim H-C. Lip repositioning surgery using an Er,Cr:YSGG laser: a case series. Int J Periodontics Restorative Dent 2020; 40 (03) 437-444
  • 101 Langelier NA, Liss J, Leyngold IM, Weller CL, Stinnett S, Woodward JA. CO2 laser lash tilt technique for the treatment of mild to moderate lash ptosis and augmentation of upper eyelid blepharoplasty results. Ophthal Plast Reconstr Surg 2019; 35 (04) 399-402